HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of cyclopiazonic acid on ischemia-reperfusion injury in rabbit hearts.

Abstract
The cardioprotective effects on myocardial ischemia of the sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA) inhibitor, cyclopiazonic acid (CPA), were studied. We used the isolated arterially perfused interventricular septum of the rabbit heart submitted to 30-min global ischemia/30-min reperfusion. Mechanical [maximal increase in resting tension (MIRT), and the recovery of developed tension (RDT)], and biochemical parameters [creatine phosphokinase activity (CPK) in the effluent] were analyzed. CPA, 1 microM, perfused 30 min before the ischemia intervention significantly increased RDT by 54% and lessened MIRT by 66%. CPA also decreased CPK in the perfusate by 67.7 and 71.4% at 0-2 and 5-7 min of reperfusion, respectively. No additional benefits were shown either when the drug was perfused, both during ischemia and reperfusion, or with higher CPA concentrations (10-30 microM). The CPA cardioprotection was lost when the drug was present only during the reperfusion period. CPA exhibits functional and biochemical cardioprotective effects on myocardial ischemia. We postulated a decreased SR calcium contribution to the initial cytoplasmic calcium overload as the most probable mechanism involved.
AuthorsM Avellanal, P Rodriguez, S Barrigon
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 32 Issue 5 Pg. 845-51 (Nov 1998) ISSN: 0160-2446 [Print] United States
PMID9821860 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Indoles
  • Creatine Kinase
  • Calcium-Transporting ATPases
  • cyclopiazonic acid
Topics
  • Animals
  • Calcium-Transporting ATPases (antagonists & inhibitors)
  • Creatine Kinase (metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Indoles (therapeutic use)
  • Myocardial Contraction (drug effects)
  • Myocardial Reperfusion Injury (prevention & control)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: